CoChat

Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo

Open access
Dalpke, Alexander H., Zimmermann, Stefan, Albrecht, Inka, Heeg, Klaus · 2002 · Immunology
Cited by 119

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Bacterial DNA and oligonucleotides (ODN) containing CpG‐motifs strongly activate cells of the immune system. Accordingly CpG‐DNA is a powerful adjuvant in vaccination protocols for B‐cell as well as for cytotoxic T‐cell responses. A decisive propensity of CpG‐DNA is its capacity to induce preferentially T helper type 1 (Th1)‐dominated immune responses. To exert its function CpG‐DNA has to be taken up by responsive cells, e.g. antigen‐presenting cells (APC). The rate of uptake is influenced by the DNA's backbone modification and critically determines activity of CpG‐DNA. CpG ODN with a phosphothioate backbone (PTO) are currently used for most in vivo and in vitro studies, since PTO modification protects ODN from the attack of nucleases. However, after administration of PTO‐modified CpG‐ODN long‐lasting effects including lymphadenopathy as well as sustained local interferon‐γ (IFN‐γ) and interleukin‐12 (IL‐12) production have been reported. To circumvent these restrictions we investigated the effects of DNA sequence as well as DNA backbone modification on cellular uptake and resulting immunostimulation. We show here that uptake of phosphodiester (PO)‐CpG‐ODN can be strongly enhanced by poly guanosine runs added at the 3′ end of the ODN. In addition these ODN showed an improved immunostimulatory activity in vivo and in vitro. This included protection of mice against lethal Th2‐dependent leishmaniasis as well as priming of antigen specific Th1 responses. More importantly, guanosine‐rich PO‐CpG‐ODN neither induced lymphadenopathy nor prolonged cytokine production after local administration. Since these improved PO ODN are efficient in vitro and in vivo and lack long lasting undesired effects they could be used preferably as adjuvants in vaccination protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2567.2002.01410.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 119

Metadata

Authors
Dalpke, A. H., Zimmermann, S., Albrecht, I., & Heeg, K.
Venue
Immunology
Publisher
Wiley
Published
2002-04-24
Volume
106
Issue
1
Pages
102-112
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W1987867113
Cited by
119
References
1
FWCI
4.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. https://app.cochat.ai/papers/10.1046/j.1365-2567.2002.01410.x
The paper
Dalpke, A. H., Zimmermann, S., Albrecht, I., & Heeg, K. (2002). Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology. https://doi.org/10.1046/j.1365-2567.2002.01410.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.